Geeta Sinha

A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis

C.P. Thakur, Thomas P. Kanyok, Avinash Pandey et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2000 · 105 citations

Open-label Trial, Medicinal Chemistry, Pharmaceutical Science +12

Comparison of three treatment regimens with liposomal amphotericin B (AmBisome®) for visceral leishmaniasis in India: a randomized dose-finding study

C.P. Thakur, Avinash Pandey, Geeta Sinha et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 1996 · 97 citations

Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study

C.P. Thakur, Thomas P. Kanyok, Avinash Pandey et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2000 · 68 citations

Injectable Paromomycin, Antibiotics, Antiparasitic Agent +10

Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases

C.P. Thakur, Geeta Sinha, Avinash Pandey et al. · Annals of Tropical Medicine and Parasitology · 1998 · 46 citations

Translational Medicine, Ventricular Fibrillation, Antiparasitic Agent +8

Amphotericin B in resistant kala-azar in Bihar.

C.P. Thakur, Geeta Sinha, Avinash Pandey et al. · PubMed · 1993 · 44 citations